Top Markets
Coin of the day
BioNexus Gene Lab Corporation BioNexus Gene Lab Corporation

BioNexus Gene Lab Corporation

BGLC
Rank in Stocks #18711
BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on... BioNexus Gene Lab Corporation, a molecular diagnostics company, focuses on developing and commercializing molecular diagnostic tests for the early detection of diseases and personalized health management primarily in Malaysia. Its non-invasive blood tests are used to analyze changes in ribonucleic acid for the detection of Covid-19, Dengue, human immunodeficiency virus, human papillomavirus, and the risk potentiality of cancers diseases. BioNexus Gene Lab Corporation was incorporated in 2017 and is based in Kuala Lumpur, Malaysia with an additional office in Sheridan, Wyoming.
Share Price
$2.49
Market Cap
$4.47M
Change (1 day)
-4.01%
Change (1 year)
678.16%
Country
MY
Trade BioNexus Gene Lab Corporation (BGLC)

Category

EPS for BioNexus Gene Lab Corporation (BGLC)
EPS as of September 2025 TTM: $-1.27
According to BioNexus Gene Lab Corporation latest financial reports and stock price the company's current EPS (TTM) is $-1.27. At the end of 2023 the company had a EPS of $-1.53 an increase over its 2022 EPS that were of $-0.25.
EPS history for BioNexus Gene Lab Corporation from 2016 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $-1.27 41.11%
2024 $-0.90 -41.18%
2023 $-1.53 512.00%
2022 $-0.25 -147.17%
2021 $0.53 -58.59%
2020 $1.28 -3,842.69%
2019 $-0.03 -812.50%
2018 0.00 -124.12%
2017 $-0.02 19,800.00%
2016 0.00 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$17.77 -1,499.21%
US
$5.07 -499.21%
US
$13.17 -1,137.01%
US
$0.74 -158.17%
CN
$4.54 -457.48%
US